The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Organ, Laura Michiko
    Director born in May 1957
    Individual (2 offsprings)
    Officer
    2010-07-15 ~ now
    OF - Director → CIF 0
  • 2
    Lagerberg, Hakan
    Chief Executive Officer born in February 1968
    Individual (1 offspring)
    Officer
    2025-04-01 ~ now
    OF - Director → CIF 0
  • 3
    Kane, John
    Executive born in March 1970
    Individual (1 offspring)
    Officer
    2025-04-01 ~ now
    OF - Director → CIF 0
  • 4
    Organ, Stephen Daniel
    Business Owner born in March 1957
    Individual (2 offsprings)
    Officer
    2009-08-12 ~ now
    OF - Director → CIF 0
  • 5
    F&L COSEC LIMITED - 2020-11-24
    Birchin Court, 5th Floor, 19-25 Birchin Lane, London, United Kingdom
    Active Corporate (3 parents, 196 offsprings)
    Equity (Company account)
    1 GBP2023-12-31
    Officer
    2013-08-09 ~ now
    OF - Secretary → CIF 0
  • 6
    Per Albin Hanssons, V. 4.1, Malmo, Sweden
    Corporate (3 offsprings)
    Person with significant control
    2025-04-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 3
  • 1
    Mrs Laura Michiko Organ
    Born in May 1957
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2025-04-01
    PE - Ownership of shares – 75% or more as a member of a firm → CIF 0
  • 2
    Mr Stephen Daniel Organ
    Born in March 1957
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2025-04-01
    PE - Ownership of shares – 75% or more as a member of a firm → CIF 0
  • 3
    REDFERN LEGAL LLP - now
    F&L LEGAL LLP
    - 2013-07-24
    8, Lincoln's Inn Fields, London, England
    Active Corporate (2 parents, 77 offsprings)
    Current Assets (Company account)
    275,375 GBP2024-04-30
    Officer
    2009-08-12 ~ 2013-08-09
    PE - Secretary → CIF 0
parent relation
Company in focus

SUMMIT VETERINARY PHARMACEUTICALS LIMITED

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Average Number of Employees
352023-04-01 ~ 2024-03-31
342022-04-01 ~ 2023-03-31
Intangible Assets
537,433 GBP2024-03-31
462,135 GBP2023-03-31
Property, Plant & Equipment
1,171,669 GBP2024-03-31
1,319,812 GBP2023-03-31
Fixed Assets
1,709,102 GBP2024-03-31
1,781,947 GBP2023-03-31
Total Inventories
625,090 GBP2024-03-31
591,729 GBP2023-03-31
Debtors
Non-current
102,000 GBP2024-03-31
102,000 GBP2023-03-31
Current
1,185,774 GBP2024-03-31
892,858 GBP2023-03-31
Cash at bank and in hand
600,271 GBP2024-03-31
1,837,040 GBP2023-03-31
Current Assets
2,513,135 GBP2024-03-31
3,423,627 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-955,804 GBP2024-03-31
-1,468,610 GBP2023-03-31
Net Current Assets/Liabilities
1,557,331 GBP2024-03-31
1,955,017 GBP2023-03-31
Total Assets Less Current Liabilities
3,266,433 GBP2024-03-31
3,736,964 GBP2023-03-31
Net Assets/Liabilities
3,077,228 GBP2024-03-31
3,584,673 GBP2023-03-31
Equity
Called up share capital
1 GBP2024-03-31
1 GBP2023-03-31
1 GBP2022-04-01
Retained earnings (accumulated losses)
3,077,227 GBP2024-03-31
3,584,672 GBP2023-03-31
3,335,644 GBP2022-04-01
Equity
3,077,228 GBP2024-03-31
3,584,673 GBP2023-03-31
3,335,645 GBP2022-04-01
Profit/Loss
Retained earnings (accumulated losses)
492,555 GBP2023-04-01 ~ 2024-03-31
999,028 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
492,555 GBP2023-04-01 ~ 2024-03-31
999,028 GBP2022-04-01 ~ 2023-03-31
Dividends Paid
Retained earnings (accumulated losses)
-1,000,000 GBP2023-04-01 ~ 2024-03-31
-750,000 GBP2022-04-01 ~ 2023-03-31
Dividends Paid
-1,000,000 GBP2023-04-01 ~ 2024-03-31
-750,000 GBP2022-04-01 ~ 2023-03-31
Equity - Income/Expense Recognised Directly
Retained earnings (accumulated losses)
-1,000,000 GBP2023-04-01 ~ 2024-03-31
-750,000 GBP2022-04-01 ~ 2023-03-31
Equity - Income/Expense Recognised Directly
-1,000,000 GBP2023-04-01 ~ 2024-03-31
-750,000 GBP2022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
Development expenditure
400,000 GBP2024-03-31
400,000 GBP2023-03-31
Computer software
215,235 GBP2024-03-31
82,228 GBP2023-03-31
Intangible Assets - Gross Cost
615,235 GBP2024-03-31
482,228 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
33,334 GBP2024-03-31
16,667 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
77,802 GBP2024-03-31
20,093 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
57,709 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
Development expenditure
366,666 GBP2024-03-31
383,333 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,063,405 GBP2024-03-31
953,800 GBP2023-03-31
Furniture and fittings
96,469 GBP2024-03-31
87,732 GBP2023-03-31
Computers
99,950 GBP2024-03-31
71,586 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
3,140,948 GBP2024-03-31
2,963,705 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
615,958 GBP2023-03-31
Furniture and fittings
43,770 GBP2023-03-31
Computers
24,703 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
1,643,892 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
96,995 GBP2023-04-01 ~ 2024-03-31
Furniture and fittings, Owned/Freehold
13,531 GBP2023-04-01 ~ 2024-03-31
Computers, Owned/Freehold
14,146 GBP2023-04-01 ~ 2024-03-31
Owned/Freehold
325,387 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
712,953 GBP2024-03-31
Furniture and fittings
57,301 GBP2024-03-31
Computers
38,849 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,969,279 GBP2024-03-31
Property, Plant & Equipment
Plant and equipment
350,452 GBP2024-03-31
337,842 GBP2023-03-31
Furniture and fittings
39,168 GBP2024-03-31
43,962 GBP2023-03-31
Computers
61,101 GBP2024-03-31
46,883 GBP2023-03-31
Raw materials and consumables
335,906 GBP2024-03-31
300,554 GBP2023-03-31
Finished Goods/Goods for Resale
289,184 GBP2024-03-31
291,175 GBP2023-03-31
Other Debtors
Non-current
102,000 GBP2024-03-31
102,000 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
981,752 GBP2024-03-31
719,065 GBP2023-03-31
Other Debtors
Current
1,891 GBP2024-03-31
28,675 GBP2023-03-31
Prepayments/Accrued Income
Current
202,131 GBP2024-03-31
145,118 GBP2023-03-31
Trade Creditors/Trade Payables
Current
411,295 GBP2024-03-31
178,690 GBP2023-03-31
Corporation Tax Payable
Current
1,369 GBP2024-03-31
Taxation/Social Security Payable
Current
310,553 GBP2024-03-31
282,582 GBP2023-03-31
Other Creditors
Current
22,478 GBP2024-03-31
764,685 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
73,727 GBP2024-03-31
103,966 GBP2023-03-31
Creditors
Current
955,804 GBP2024-03-31
1,468,610 GBP2023-03-31
Net Deferred Tax Liability/Asset
-189,205 GBP2024-03-31
-152,291 GBP2023-03-31
-126,322 GBP2022-04-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-36,914 GBP2023-04-01 ~ 2024-03-31
-25,969 GBP2022-04-01 ~ 2023-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
-194,825 GBP2024-03-31
-155,962 GBP2023-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
217,090 GBP2024-03-31
184,500 GBP2023-03-31
Between one and five year
272,824 GBP2024-03-31
403,125 GBP2023-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
489,914 GBP2024-03-31
587,625 GBP2023-03-31
  • SUMMIT VETERINARY PHARMACEUTICALS LIMITED
    Info
    Registered number 06989197
    Birchin Court 5th Floor, 19-25 Birchin Lane, London EC3V 9DU
    Private Limited Company incorporated on 2009-08-12 (15 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-12
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.